JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on November 29, 2006; DOI: 10.1124/jpet.106.112631


0022-3565/07/3203-978-985$20.00
JPET 320:978-985, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.112631v1
320/3/978    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Naud, J.
Right arrow Articles by Pichette, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Naud, J.
Right arrow Articles by Pichette, V.

METABOLISM, TRANSPORT, AND PHARMACOGENOMICS

Down-Regulation of Intestinal Drug Transporters in Chronic Renal Failure in Rats

Judith Naud, Josée Michaud, Caroline Boisvert, Karine Desbiens, Francois A. Leblond, Andrew Mitchell, Christine Jones, Alain Bonnardeaux, and Vincent Pichette

Service de Néphrologie et Centre de Recherche Guy-Bernier, Hôpital Maisonneuve-Rosemont (J.N., J.M., C.B., K.D., F.A.L., A.B., V.P.) and Département de Pharmacologie (J.N., J.M., C.B., V.P.), Facultéde Médecine, Université de Montréal, Montreal, Quebec, Canada; Service de Pathologie, Hôpital Maisonneuve-Rosemont, Montreal, Quebec, Canada (A.M.); and Département d'Anatomie et de Biologie Cellulaire, Université de Sherbrooke, Sherbrooke, Quebec, Canada (C.J.)

Chronic renal failure (CRF) is associated with an increased bioavailability of drugs by a poorly understood mechanism. One hypothesis is a reduction in the elimination of drugs by the intestine, i.e., drug elimination mediated by protein membrane transporters such as P-glycoprotein (Pgp) and multidrug-resistance-related protein (MRP) 2. The present study aimed to investigate the repercussions of CRF on intestinal transporters involved in drug absorption [organic anion-transportingpolypeptide (Oatp)] and those implicated in drug extrusion (Pgp and MRP2). Pgp, MRP2, MRP3, Oatp2, and Oatp3 protein expression and Pgp, MRP2, and Oatp3 mRNA expression were assessed in the intestine of CRF (induced by five-sixth nephrectomy) and control rats. Pgp and MRP2 activities were measured using the everted gut technique. Rat enterocytes and Caco-2 cells were incubated with sera from control and CRF rats to characterize the mechanism of transporters' down-regulation. Protein expression of Pgp, MRP2, and MRP3 were reduced by more than 40% (p < 0.01) in CRF rats, whereas Oatp2 and Oatp3 expression remained unchanged. There was no difference in the mRNA levels assessed by real-time polymerase chain reaction. Pgp and MRP2 activities were decreased by 30 and 25%, respectively, in CRF rats compared with control (p < 0.05). Uremic sera induced a reduction in protein expression and in activity of drug transporters compared with control sera. Our results demonstrate that CRF in rats is associated with a decrease in intestinal Pgp and MRP2 protein expression and function secondarily to serum uremic factors. This reduction could explain the increased bioavailability of drugs in CRF.


Received for publication August 17, 2006
Accepted November 27, 2006.

Address correspondence to: Dr. Vincent Pichette, Centre de Recherche Guy-Bernier, Hôpital Maisonneuve-Rosemont, 5415 Boulevard de l'Assomption, Montreal, Quebec, Canada H1T 2M4. E-mail: vpichette.hmr{at}ssss.gouv.qc.ca




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
T. D. Nolin, R. F. Frye, P. Le, H. Sadr, J. Naud, F. A. Leblond, V. Pichette, and J. Himmelfarb
ESRD Impairs Nonrenal Clearance of Fexofenadine but not Midazolam
J. Am. Soc. Nephrol., October 1, 2009; 20(10): 2269 - 2276.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
T. Nakano, S. Sekine, K. Ito, and T. Horie
Correlation between Apical Localization of Abcc2/Mrp2 and Phosphorylation Status of Ezrin in Rat Intestine
Drug Metab. Dispos., July 1, 2009; 37(7): 1521 - 1527.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
E. Simard, J. Naud, J. Michaud, F. A. Leblond, A. Bonnardeaux, C. Guillemette, E. Sim, and V. Pichette
Downregulation of Hepatic Acetylation of Drugs in Chronic Renal Failure
J. Am. Soc. Nephrol., July 1, 2008; 19(7): 1352 - 1359.
[Full Text] [PDF]


Home page
IOVSHome page
V. E. Tovell and J. Sanderson
Distinct P2Y Receptor Subtypes Regulate Calcium Signaling in Human Retinal Pigment Epithelial Cells
Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 350 - 357.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
H. Lu and C. Klaassen
Gender Differences in mRNA Expression of ATP-Binding Cassette Efflux and Bile Acid Transporters in Kidney, Liver, and Intestine of 5/6 Nephrectomized Rats
Drug Metab. Dispos., January 1, 2008; 36(1): 16 - 23.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
J. Naud, J. Michaud, F. A. Leblond, S. Lefrancois, A. Bonnardeaux, and V. Pichette
Effects of Chronic Renal Failure on Liver Drug Transporters
Drug Metab. Dispos., January 1, 2008; 36(1): 124 - 128.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
V. Petrovic, S. Teng, and M. Piquette-Miller
REGULATION OF DRUG TRANSPORTERS: DURING INFECTION AND INFLAMMATION
Mol. Interv., April 1, 2007; 7(2): 99 - 111.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.